deltorphin i, ala(2)- has been researched along with h 89 in 1 studies
| Studies (deltorphin i, ala(2)-) | Trials (deltorphin i, ala(2)-) | Recent Studies (post-2010) (deltorphin i, ala(2)-) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
|---|---|---|---|---|---|
| 122 | 0 | 4 | 1,619 | 0 | 409 |
| Protein | Taxonomy | deltorphin i, ala(2)- (IC50) | h 89 (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagley, EE; Chieng, BC; Christie, MJ; Hack, SP | 1 |
1 other study(ies) available for deltorphin i, ala(2)- and h 89
| Article | Year |
|---|---|
Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Excitatory Amino Acid Antagonists; G Protein-Coupled Inwardly-Rectifying Potassium Channels; gamma-Aminobutyric Acid; Glycine Agents; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Narcotic Antagonists; Narcotics; Neurons; Oligopeptides; Patch-Clamp Techniques; Periaqueductal Gray; Protein Kinase Inhibitors; Receptors, Opioid, delta; Receptors, Opioid, mu; Strychnine; Sulfonamides; Synaptic Transmission; Time Factors; Xanthines | 2005 |